Menu Search
Equities

RadNet Inc

RDNT:NMQ

RadNet Inc

Actions
Health CareHealth Care Providers
  • Price (USD)69.57
  • Today's Change2.46 / 3.67%
  • Shares traded869.67k
  • 1 Year change+147.58%
  • Beta1.7440
Data delayed at least 15 minutes, as of Sep 19 2024 20:59 BST.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Financials data is unavailable for this security.

Inc stmt in USDIncome statement in USDView more

Year on year RadNet Inc had net income fall -71.42% from 10.65m to 3.04m despite revenues that grew 13.05% from 1.43bn to 1.62bn over the same period.
Gross margin22.82%
Net profit margin2.48%
Operating margin6.13%
Return on assets1.43%
Return on equity1.35%
Return on investment1.83%
More ▼

Cash flow in USDView more

In 2023, RadNet Inc increased its cash reserves by 167.98%, or 214.74m. The company earned 220.86m from its operations for a Cash Flow Margin of 13.66%. In addition the company generated 195.64m cash from financing while 201.47m was spent on investing.
Cash flow per share2.49
Price/Cash flow per share28.50
Book value per share11.91
Tangible book value per share1.19
More ▼

Balance sheet in USDView more

RadNet Inc has a Debt to Total Capital ratio of 48.44%, a lower figure than the previous year's 143.02%.
Current ratio2.12
Quick ratio--
Total debt/total equity1.17
Total debt/total capital0.4844
More ▼

Growth rates in USD

Year on year, growth in earnings per share excluding extraordinary items dropped -74.66%. Additionally, five year annualized earnings per share growth ranks below the industry average relative to its peers.
EPS growth(5 years)-41.07
EPS (TTM) vs
TTM 1 year ago		163.44
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.